A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study

D. Scott McMeekin; Michael W. Sill; Joan L. Walker; Kathleen N. Moore; Steven E. Waggoner; Premal H. Thaker; Tina Rizack; James S. Hoffman; Paula M. Fracasso

doi:10.1097/01.ogx.0000471706.11154.3b

A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study

D. Scott McMeekin, Michael W. Sill, Joan L. Walker, Kathleen N. Moore, Steven E. Waggoner, Premal H. Thaker, Tina Rizack, James S. Hoffman, Paula M. Fracasso

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	626-628
Number of pages	3
Journal	Obstetrical and Gynecological Survey
Volume	70
Issue number	10
DOIs	https://doi.org/10.1097/01.ogx.0000471706.11154.3b
State	Published - 2015

Access to Document

10.1097/01.ogx.0000471706.11154.3b

Cite this

McMeekin, D. S., Sill, M. W., Walker, J. L., Moore, K. N., Waggoner, S. E., Thaker, P. H., Rizack, T., Hoffman, J. S., & Fracasso, P. M. (2015). A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study. Obstetrical and Gynecological Survey, 70(10), 626-628. https://doi.org/10.1097/01.ogx.0000471706.11154.3b

@article{a793d6b5614f446a8585f2175806d506,

title = "A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study",

author = "McMeekin, {D. Scott} and Sill, {Michael W.} and Walker, {Joan L.} and Moore, {Kathleen N.} and Waggoner, {Steven E.} and Thaker, {Premal H.} and Tina Rizack and Hoffman, {James S.} and Fracasso, {Paula M.}",

year = "2015",

doi = "10.1097/01.ogx.0000471706.11154.3b",

language = "English",

volume = "70",

pages = "626--628",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

number = "10",

}

McMeekin, DS, Sill, MW, Walker, JL, Moore, KN, Waggoner, SE, Thaker, PH, Rizack, T, Hoffman, JS & Fracasso, PM 2015, 'A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study', Obstetrical and Gynecological Survey, vol. 70, no. 10, pp. 626-628. https://doi.org/10.1097/01.ogx.0000471706.11154.3b

A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study. / McMeekin, D. Scott; Sill, Michael W.; Walker, Joan L. et al.
In: Obstetrical and Gynecological Survey, Vol. 70, No. 10, 2015, p. 626-628.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920)

T2 - An NRG oncology/gynecologic oncology group study

AU - McMeekin, D. Scott

AU - Sill, Michael W.

AU - Walker, Joan L.

AU - Moore, Kathleen N.

AU - Waggoner, Steven E.

AU - Thaker, Premal H.

AU - Rizack, Tina

AU - Hoffman, James S.

AU - Fracasso, Paula M.

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84944411501&partnerID=8YFLogxK

U2 - 10.1097/01.ogx.0000471706.11154.3b

DO - 10.1097/01.ogx.0000471706.11154.3b

M3 - Comment/debate

AN - SCOPUS:84944411501

SN - 0029-7828

VL - 70

SP - 626

EP - 628

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 10

ER -

McMeekin DS, Sill MW, Walker JL, Moore KN, Waggoner SE, Thaker PH et al. A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study. Obstetrical and Gynecological Survey. 2015;70(10):626-628. doi: 10.1097/01.ogx.0000471706.11154.3b

A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study

Access to Document

Other files and links

Cite this